Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2010, Article ID 383548, 3 pages
http://dx.doi.org/10.4061/2010/383548
Case Report

Severe Relapsing Goodpasture's Disease Successfully Treated with Mycophenolate Mofetil

Serviço de Nefrologia, Hospital de Faro, Rua Leão Penedo, 8000 Faro, Portugal

Received 21 April 2010; Revised 22 June 2010; Accepted 14 July 2010

Academic Editor: Tibor Nadasdy

Copyright © 2010 Anabela Malho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Valle, S. Pimenta, P. Pinto, C. Valbuena, M. Dias, and F. C. Chaves, “Lung-kidney syndrome,” Acta Medica Portuguesa, vol. 18, no. 3, pp. 235–240, 2005. View at Google Scholar · View at Scopus
  2. P. Giri and J. E. Taylor, “Recurrent goodpasture's disease with severe renal involvement after initial successful treatment,” Nephrology Dialysis Transplantation, vol. 16, no. 9, p. 1952, 2001. View at Google Scholar · View at Scopus
  3. W. K. Bolton, “Goodpasture's syndrome,” Kidney International, vol. 50, no. 5, pp. 1753–1766, 1996. View at Google Scholar · View at Scopus
  4. J. B. Levy, R. H. Lachmann, and C. D. Pusey, “Recurrent Goodpasture's disease,” American Journal of Kidney Diseases, vol. 27, no. 4, pp. 573–578, 1996. View at Google Scholar · View at Scopus
  5. F. Merkel, K.-O. Netzer, O. Gross, M. Marx, and M. Weber, “Therapeutic options for critically ill patients suffering from progressive lupus nephritis or Goodpasture's syndrome,” Kidney International, vol. 53, no. 64, pp. S31–S38, 1998. View at Google Scholar · View at Scopus
  6. J. B. Levy, A. N. Turner, A. J. Rees, and C. D. Pusey, “Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression,” Annals of Internal Medicine, vol. 134, no. 11, pp. 1033–1042, 2001. View at Google Scholar · View at Scopus
  7. G. B. Appel, J. Radhakrishnan, and E. M. Ginzler, “Use of mycophenolate mofetil in autoimmune and renal diseases,” Transplantation, vol. 80, no. 2, pp. S265–S271, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. P. M. Stassen, C. G. M. Kallenberg, and C. A. Stegeman, “Use of mycophenolic acid in non-transplant renal diseases,” Nephrology Dialysis Transplantation, vol. 22, no. 4, pp. 1013–1019, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. W. A. Briggs, M. J. Choi, and P. J. Scheel Jr., “Successful mycophenolate mofetil treatment of glomerular disease,” American Journal of Kidney Diseases, vol. 31, no. 2, pp. 213–217, 1998. View at Google Scholar · View at Scopus
  10. T. M. Sievers, S. J. Rossi, R. M. Ghobrial et al., “Mycophenolate mofetil,” Pharmacotherapy, vol. 17, no. 6, pp. 1178–1197, 1997. View at Google Scholar · View at Scopus
  11. K. G. Smith, N. M. Isbel, M. G. Catton, J. A. Leydon, G. J. Becker, and R. G. Walker, “Suppression of the humoral immune response by mycophenolate mofetil,” Nephrology Dialysis Transplantation, vol. 13, no. 1, pp. 160–164, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. A. C. Allison and E. M. Eugui, “Mycophenolate mofetil and its mechanisms of action,” Immunopharmacology, vol. 47, no. 2-3, pp. 85–118, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Garcia-Cantón, A. Toledo, R. Palomar et al., “Goodpasture's syndrome treated with mycophenolate mofetil,” Nephrology Dialysis Transplantation, vol. 15, no. 6, pp. 920–922, 2000. View at Google Scholar · View at Scopus